All News Top News Jul 15, 2019 Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder Learn More Share Top News Jul 11, 2019 Teva Drives Progress to Address Pressing Global Health Challenges While Maintaining Focus on Compliance Learn More Share Top News Jul 11, 2019 Teva Completes Facilities Purchase in Pennsylvania for North America Research & Development Campus Learn More Share Top News Jul 10, 2019 Teva to Present New Data on AJOVY® (fremanezumab-vfrm) Injection at the American Headache Society’s 61st Annual Scientific Meeting Learn More Share Top News Jul 3, 2019 Teva to Host Conference Call to Discuss Second Quarter 2019 Financial Results at 8 a.m. ET on August 7, 2019 Learn More Share
Top News Jul 15, 2019 Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder Learn More
Top News Jul 11, 2019 Teva Drives Progress to Address Pressing Global Health Challenges While Maintaining Focus on Compliance Learn More
Top News Jul 11, 2019 Teva Completes Facilities Purchase in Pennsylvania for North America Research & Development Campus Learn More
Top News Jul 10, 2019 Teva to Present New Data on AJOVY® (fremanezumab-vfrm) Injection at the American Headache Society’s 61st Annual Scientific Meeting Learn More
Top News Jul 3, 2019 Teva to Host Conference Call to Discuss Second Quarter 2019 Financial Results at 8 a.m. ET on August 7, 2019 Learn More